Combined model integrating clinical, radiomics, BRAF^V600E and ultrasound for differentiating between benign and malignant indeterminate cytology (Bethesda III) thyroid nodules: a bi-center retrospective study.

Our predictive model based on conventional US features and BRAF V600E shows that combining capsule contact, C-TIRADS, and BRAF V600E mutations can assist in distinguishing the benignity and malignancy of thyroid nodules with indeterminate significance.

also in 137 other papers